A Welsh MedTech company is taking next steps towards launching its unique technology, after securing a partnership with a leading medical devices company.
Article continues below
Ceryx Medical is working with Berlin-based Osypka Medical to develop a heart pacing device that it says will change the way patients with heart failure and other cardiac conditions are treated.
Ceryx’s bionic device, Cysoni, takes pacemaking to a new level by pacing the heart with real-time modulation.
Unlike traditional pacemakers, Cysoni prompts the heart to beat in line with the patient’s breathing. It means the device listens and responds to the body, rather than triggering the strict metronomic beats that current pacemakers do.
The scientists behind this say there are huge advantages to this approach.
Ceryx’s CEO, Dr Stuart Plant, said, "It’s a huge breakthrough in the treatment of people with even the most serious heart conditions. Our studies show that Cysoni increases cardiac output by at least 20% when compared with monotonic pacing while at the same time it enables heart cells to repair themselves. This is a ground-breaking development for patients with conditions such as heart failure, who will have the opportunity to live longer, fuller lives"
The partnership will see Ceryx’s Cysoni device combined with Osypka Medical’s pacemaker for the purpose of in-human testing. This clinical study is scheduled to take place in the 3rd quarter of 2023 and will take Ceryx closer to commercialising its technology.
Over the next few months, the teams at Ceryx and Osypka will work together to refine the device for clinical trials, which will take place in the UK and New Zealand.
This will involve heart failure patients who have undergone a coronary artery bypass being fitted with this external device. These patients are usually paced for just a few hours after surgery, but the Ceryx team plans to extend this in order to build a full picture of Cysoni’s capabilities. ■
The International Air Transport Association (IATA) called on both the Danish and Icelandic Air Navigation Service Providers (ANSP) to revoke the planned increases in air traffic charges set to come into effect on 1 January 2023.